FDA approves second Alzheimer’s drug that can slow onset of disease The GuardianFDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease CNNFDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S. CNBCFDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s The New York Times